CCL2 and breast neoplasm: These structures release pro-inflammatory factors, including interleukins (IL-6, IL-8), monocyte chemotactic protein (MCP-1), and tumor necrosis factor alpha (TNFα), which promote a pro-inflammatory environment in the breast tumor microenvironment, thereby facilitating the development of BC (45).